Free Trial
ASX:PNR

Pantoro (PNR) Stock Price, News & Analysis

Pantoro logo

About Pantoro Stock (ASX:PNR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.07 million shs
Average Volume
N/A
Market Capitalization
A$935.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PNR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pantoro and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PNR Stock News Headlines

BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
See More Headlines

PNR Stock Analysis - Frequently Asked Questions

Pantoro Limited (ASX:PNR) released its quarterly earnings data on Thursday, March, 15th. The company reported $0.01 earnings per share (EPS) for the quarter. Pantoro had a negative net margin of 21.49% and a negative trailing twelve-month return on equity of 12.91%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pantoro investors own include bluebird bio (BLUE), Cummins (CMI), L3 Technologies (LLL), Argonaut Gold (AR), Athene (ATH), BELLUS Health (BLU) and Esperion Therapeutics (ESPR).

Company Calendar

Last Earnings
3/15/2018
Today
8/27/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Gold
Sub-Industry
Machinery
Current Symbol
ASX:PNR
CIK
N/A
Fax
N/A
Employees
11,200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$49.31 million
Net Margins
-21.49%
Pretax Margin
N/A
Return on Equity
-12.91%
Return on Assets
-7.08%

Debt

Debt-to-Equity Ratio
13.58
Current Ratio
1.39
Quick Ratio
1.26

Sales & Book Value

Annual Sales
A$229.43 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
5.40
Book Value
A$0.08 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
6,450,000,000
Free Float
N/A
Market Cap
A$935.83 million
Optionable
Not Optionable
Beta
1.42
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:PNR) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners